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PURPOSE: The aim of this study was to standardize the methods of sample collection of mucus from the digestive tract and to
determine the microbiota in healthy volunteers from Brazil, collecting samples from the mouth, esophagus, stomach, duodenum,
jejunum, ileum, colon, and rectum.
METHODS: Microbiota of selected healthy volunteers from the oral cavity (n=10), the esophagus (n=10), the upper digestive
tract (n=20), and the lower digestive tract (n=24) were evaluated through distinct collection methods. Collection methods took
into account the different sites, using basic scraping and swabbing techniques, stimulated saliva from the oral cavity, irrigation-
aspiration with sterile catheters especially designed for the esophagus, a probe especially designed for upper digestive tract, and
a special catheter for the lower digestive tract.
RESULTS: (i) Mixed microbiota were identified in the oral cavity, predominantly Gram-positive aerobic and anaerobic cocci; (ii)
transitional flora mainly in the esophagus; (iii) Veillonella sp, Lactobacillus sp, and Clostridium sp in the stomach and duodenum;
(iv) in the jejunum and upper ileum, we observed Bacteroides sp, Proteus sp, and Staphylococcus sp, in addition to Veillonella sp;
(v) in the colon, the presence of “nonpathogenic” anaerobic bacteria Veillonella sp (average 105 UFC) indicates the existence of a
low oxidation-reduction potential environment, which suggests the possibility of adoption of these bacteria as biological markers
of total digestive tract health.
CONCLUSIONS: The collection methods were efficient in obtaining adequate samples from each segment of the total digestive
tract to reveal the normal microbiota. These procedures are safe and easily reproducible for microbiological studies.
KEYWORDS: Bacteria Anaerobic. Bacteria Aerobic. Fungi. Colony count microbial. Gastrointestinal tract.
INTRODUCTION
Interest in the microbiologic composition of the normal
digestive tract began in the 19th century with Pasteur, who
believed that a symbiotic relationship between man and
bacteria was essential to life. However, at the beginning
of the 20th century, several authors including Metchnikoff
et al1 believed that microbiota competed with the host or-
ganism for nutrients. The development of experimental
models to study the relationship between microbiota and
the human organism in totally germ-free laboratory animals
demonstrated the role of the normal microflora in vitamin
synthesis, metabolism of nitrogen compounds and lipids,
and especially their participation as a barrier against the
invasion of pathogenic microorganisms.2-4 In 1964,
Donaldson5 standardized the quantitative analysis of bac-
teria in the feces of healthy volunteers, and in 1966, Kalser6
described an aspiration sampling technique for studying the
microbiota of the jejunum and ileum. There have been few
advances in collection methods since then; however, there
48
CLINICS 2007;62(1):47-54Digestive tract microbiota in healthy volunteers
Zilberstein B et al.
have been some improvements in cultivation techniques and
the use of genetic probes for identification of the microor-
ganism.7
Over the last 20 years, there has been an increased in-
terest in the study of the microbiota and their role in dis-
eases of the digestive system including neoplasias,8,9 intes-
tinal inflammatory disease,10,11 diarrhea associated with an-
tibiotic use,12-14 and bacterial translocation.15,16 However,
one of the difficulties in performing conclusive repeatable
studies has always been the lack of a standard collection
method that can be used to establish a uniform control
group of healthy individuals against which the different dis-
eases could be compared.
This shortcoming becomes even more important when
there is the intention to study the eventual modification of
the normal microbiota caused by or as a consequence of
digestive diseases.11,17
The aim of this study was to standardize collecting sam-
ple methods from the different segments of the digestive
tract in healthy volunteers in order to better characterize
their microbiota.
PATIENTS AND METHODS
A multidisciplinary prospective investigation was de-
veloped involving the Digestive Surgery Division and the
Gastrointestinal Endoscopy Unit of the São Paulo Univer-
sity Medical School, and the Institute of Biomedical Sci-
ences of the University of São Paulo.
The study was approved by the Ethic Committees and
informed consent was obtained from all volunteers.
The different segments of the digestive tract were stud-
ied in separate groups of healthy volunteers. Sample col-
lection methods were specifically developed for each seg-
ment. Healthy individuals were selected based on the fol-
lowing exclusion criteria: use of antibiotics and/or anti-in-
flammatory drugs in the preceding 90 days, dental pros-
theses, smoking, alcoholism, diabetes, presence of malig-
nant tumors, scleroderma, previous surgical procedures on
the digestive tract, or any other problem that could affect
the digestive tract, the esophagus, stomach, intestines, or
specifically the mouth flora; a dental caries index (CPO –
D) greater than 2.618 was also was also an exclusion crite-
rion.
Standardized collection method from the mouth. Ten
healthy individuals were prospectively studied, including
5 men and 5 women, with a mean age of 33.3 years. Sam-
ples for microbiological study were collected from saliva,
the back of the tongue, and supragingival and subgingival
bacterial biofilm. A sterile Petri dish was used for saliva
collection after stimulation by masticatory mouth move-
ments. From the back of the tongue, a sterile cotton swab
was used with a front-to-back movement. The supragingival
bacterial biofilm was collected from the vestibular face of
the first lower left molar and from the subgingival vestibular
face of the contralateral first molar with a periodontal
(Gracey) curette (Figure 1). The collected materials were
placed in a test tube containing phosphate-buffered saline
for immediate transport.
Standardized collection method from the esophagus.
Ten individuals were prospectively studied, including 6
women and 4 men, with a mean age of 43.4 years. Volun-
teers were selected among those who were going to un-
dergo an upper digestive tract endoscopy. After local mouth
anesthetic with 10% lidocaine spray and intravenous se-
dation with diazepam (3-5 mg), a nº14(Fr) Levine catheter
was introduced with extreme care into the mouth through
an nº7.5 or 29 Fr orotracheal tube. The catheter was pushed
forward to touch the esophagus lumen, where 10 mL of
saline was injected using a 20 mL syringe connected to its
proximal end; aspiration was then performed. The collected
material was transported in a phosphate buffer saline solu-
tion (1 mL/9 mL) to the microbiology laboratory within 1
hour (Figure 2). Upper digestive endoscopy was then im-
mediately performed to identify any abnormality of the
upper digestive tract.
Standardized collection method from the stomach,
duodenum, jejunum, and proximal ileum. This was per-
formed in 20 other volunteers: 8 men and 12 women with
a mean age of 42 years. All individuals presented normal
upper digestive tract endoscopies. A flexible silicone sam-
pling probe was used with a small (3 mm) distal opening
and with a lead weight bound in its extremity.19-23 This
Figure 1 - Saliva; back of the tongue; sub-gingival biofilm
Figure 2 - Levine nº 14 catheters; 20 ml syringe; phosphate buffer solution
(1ml/9ml); 10 ml of saline solutions; nº 7.5 orotracheal cannula
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probe was introduced by mouth and swallowed until it
reached the stomach, being located by radioscopy. The first
sample was collected, aspirating 1 mL of mucus with a 20
mL syringe connected to its proximal end. The probe was
allowed to migrate by peristaltic movement to the more
distal segments and was periodically monitored by
radioscopy (Figure 3). The same probe was used for col-
lection of material in each intestinal segment. The evalua-
tion of the exact site from which the mucus was obtained
was determined by the length of the probe introduced and
its location through radioscopy. To avoid contamination and
eventual false results, the probe was washed out several
times, and the contents were discarded before the actual
collection of mucus. A series of 1-mL samples was taken
from the duodenum, proximal jejunum, distal jejunum, and
proximal ileum. The samples were placed into the test tubes
with 9 mL of phosphate buffer saline solution and taken
to the microbiology laboratory within the first hour.
Standardized collection method from distal ileum, co-
lon, and rectum. This method was performed in another 24
volunteers, 10 men and 14 women, with a mean age of 53
years, through colonoscopy after previous colon preparation
with a 10% mannitol solution until the stool was liquid, clear,
and free of residues.24 Colonoscopy was performed at least
5 hours after the colonic preparation to avoid interference
in the determination of the microbiologic contents of the co-
lonic mucus.25 Colonoscopy was performed after sedation
with diazepam (to 10 mg) and meperidine (to 100 mg). The
colonoscope was introduced into the distal ileum, checking
the integrity of the lower digestive tract (distal ileum; cecum;
ascending, transverse, descending, and sigmoid colon; and
rectum). A proper catheter, especially developed for this pur-
pose, was used to pass through the working channel of the
colonoscope to collect the samples of mucus from the dif-
ferent segments of the lower digestive tract. This catheter,
obtained from a polyethylene probe, was especially designed,
being 2.20 m long and 8 Fr in diameter; it was internally
coated with silicone (Figure 4). The distal end of the cath-
eter was covered by a protective membrane; this was rup-
tured at the time of collection by inflation with air. Sample
volume was always 0.1 mL, determined by step marks on
the distal end of the catheter5,2,25-27 that could be visualized
by the colonoscope. A fresh sterile catheter was used at each
site of the lower digestive tract for collecting the samples.
After collection, the samples were taken to the microbio-
logical laboratory in a sterile Eppendorf tube containing 0.9
mL of VMGA III (viability-maintaining transport medium).28
Culture media
The collected materials from all segments were placed
in selective culture media for aerobic and anaerobic mi-
croorganisms and yeasts.29 The following culture media
were used: Sabouraud agar *, MacConkey agar**-blood,
Enterococcus-selective agar**, reinforced Clostridium me-
dium** ; Phenylethylalcohol agar*, Veillonella medium*,
Brain-Heart infusion (BHI) agar* + vitamin K + hemin +
streptomycin, Chapman-Stone medium**, Bacteroides
fragilis bile-esculin agar medium (BBE) *, Bifidobacterium
medium, Propionibacterium medium*, BHI* + extract of
yeast, Blood-trypticase soy agar (TSA) * + vitamin K +
hemin (*DIFCO. St. Louis, MO, USA; **MERCK
DIAGNOSTICA, RJ, Brazil).
Statistical analysis
Descriptive analysis of findings from the mouth,
esophagus, and upper digestive tract was done. The chi
square (X2) test was used to verify the difference in distri-
bution of each bacterial species in the various regions of
the lower digestive tract. The expected frequency of each
bacterial species in different regions of the lower digestive
tract was calculated using nonparametric tests.30
The results of the concentration of microorganisms were
expressed in units of colony formation/mL (ucf) expressed
in logarithm base 10 (log10). Significance was assigned to
a P value of < 0.05.
Figure 3 - Agar-blood; Bile esculin (BBE); Tioglicolato; Flexible silicone
sampling probe with distal orifice and lead weight bound to extremity
Figure 4 - Catheter for sampling ependdorff tube
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RESULTS
Mouth microbiota. Table 1 shows the frequency and
locations of microorganisms found in the mouth. Mixed
microbiota were identified here, with as predominance of
Gram-positive aerobic and anaerobic cocci
Esophagus microbiota. Table 2 shows the frequency
and average concentration of microorganisms found in the
esophagus. It can be seen that in this segment the flora is
transitional.
Stomach, duodenum, jejunum, and proximal ileum
microbiota. Table 3 shows the mean concentrations and
prevalence of the different microorganisms found in each
segment of the upper digestive tract. Veillonella sp, Lacto-
bacillus sp, and Clostridium sp are predominant in the
stomach and duodenum; while Bacteroides sp, Proteus sp,
and Staphylococcus sp, in addition to Veillonella sp are pre-
dominant in the jejunum and upper ileum;
Distal ileum, colon, and rectum microbiota. Table 4
shows the different microorganisms found in each segment.
The most distinctive feature here is the presence of “nonpatho-
genic” anaerobic bacteria Veillonella sp (average 105 UFC)
Table 5 shows the association between microorganisms
and sites of the lower digestive tract.
DISCUSSION
The complex interactions between the different micro-
organisms or between them and healthy hosts or their in-
teraction in digestive diseases are poorly understood. The
study of the microbiota in humans starts with the need for
standardizing sample collection methods from the differ-
ent segments of the digestive tract, including availability
of different technical resources and ethical issues. This base
is necessary when we intend to compare different studies.
This investigation describes the sample collection meth-
ods from different segments of the digestive tract. This
methodology is characterized by the following character-
istics: (i) it is innocuous for patients; (ii) it allows mate-
rial to be collected from restricted sites, avoiding contami-
nation; (iii) it uses available materials with accessible
prices, and (iv) it is easily reproducible.
Material sampling from the mouth18,31,32 and esophagus33
was done by modifying previously validated methods al-
ready described in the literature. For the stomach, duode-
num, jejunum (proximal and distal), and proximal ileum,
similar methods were used.19-22 Finally, samples from the
distal ileum, colon, and rectum were collected using a new
method developed by the authors.28
The oral cavity presented very diverse microbiota due
to the different anatomical sites and constant exposure to
the external environment. The method of collecting saliva
without using chewing gum or paraffin tablets gave better
results than in previous studies,34-38 suggesting that the tech-
nique used in this study is more sensitive and causes fewer
alterations to indigenous flora. Results from the back of
the tongue were similar to those of other studies.35-38
Periodontal Gracey curettes were preffered for sampling
from the supra- and subgingival biofilm. Our results were
Table 1 - Frequency and locations of microorganisms in the oral cavity
Microorganism Saliva (%) Tongue (%) Superior Biofilm (%) Inferior Biofilm (%)
Actinomyces sp 40 30 30 20
Anaerobic rods (Gram- pig) 30 10 50 10
Anaerobic rods (Gram- npg) 10 0 0 0
Candida sp 20 30 10 0
Corynebacterium sp 70 40 20 20
Escherichia coli 10 20 20 0
Fusobacterium sp 60 0 40 0
Lactobacillus sp 90 50 30 0
Neisseria sp 0 40 0 0
Neisseria sp 0 40 0 0
Peptostreptococcus sp 70 50 50 20
Propionibacterium sp 20 30 60 30
Staphylococcus sp (coag-) 50 30 10 10
Streptococcus sp (alpha- hemolytic) 100 90 90 80
Streptococcus sp (gamma- hemolytic) 20 10 0 10
Veillonella sp 100 60 80 70
sp = species; pig = pigmented; npg = nonpigmented; coag- = coagulase negative
Table 2 - Frequency and concentration of microorganisms
in the esophagus
 Frequency (%) Concentration (ufc/mL)
Streptococcus sp 40 101
Staphylococcus sp 20 102
Corynebacterium sp 10 102
Lactobacillus sp 10 102
Peptococcus sp 10 101
sp = species
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similar to those reported in the literature,32,38,39 validating
this method.
From a microbiological point of view, the esophagus
has always been considered to be a saliva secretion pas-
sageway with transitory microbiota similar to the mouth
and of little interest in research. However, when alimen-
tary stasis occurs, as in neoplasia or achalasia,40,41 there is
an excessive increase in bacterial growth, with the risk of
serious infections after surgery or endoscopy.42,43
Sample collection for studying the microbiota of the
esophagus cannot be performed with catheters that pass
through the mouth because of the risk of contamination
during their insertion. The use of sterile catheters that pass
through the working channel of an endoscope is expensive
and does not permit aspiration of sufficient thick material
from an esophagus with stasis.
Gagliardi et al33 developed a similar collection method
to that used in our study. However, by taking the samples
before endoscopic examination, we avoided possible con-
tamination during the introduction or removal of the en-
doscopic device. This small technical modification enabled
us to obtain fewer positive cultures (40% vs 66%) with
similar strains of bacteria, with predominantly Gram posi-
tive aerobes and without Gram negative aerobes, as de-
scribed by Gagliardi in 13% of cases.
The samples obtained from the stomach for microbio-
logical study presented no problems because of the ease
of access, and because gastric pH is responsible for the de-
struction of most swallowed bacteria, all of which facili-
tates the isolation of the appropriate microorganisms.19
In the stomach, there was a predominance of Lactoba-
cillus sp, Veillonella sp, and Clostridium sp, which are all
resistant to the acid environment, demonstrating potential
residual microflora that could develop down to the lower
regions of the digestive tract.
Other species such as Escherichia coli, Peptococcus sp,
Table 3 - Mean concentration and prevalence of microorganism in the upper digestive tract
Site STOMACH DUODENUM JEJUNUM ILEUM
Proximal Distal Proximal
Microorganisms MC % MC % MC % MC % MC %
Bacillus sp 4 9.1
Bacteroides sp 2 9.1 3 9.1
Bacteroides sp (npg) 2 16 2 9.1 3.5 36.4 3 45.5 4.5 40.0
Bifidobacterium sp 3 9.1 3 9.1
Candida sp 2 9.1 3 18.2 1 10.0
Clostridium ramosum
Clostridium sp
Clostridium sp (gel-) 4 33.3 2 27.3 2.5 18.2 5 27.3 3.5 20.0
Clostridium sp (gel+)
Corynebacterium sp 3 25 3 18.2 2 9.1 5.5 18.2 3 30.0
Escherichia coli 5.5 16 2.5 18.2 5.5 18.2 6 36.4 3 30.0
Enterobacter sp 7 8.3 5 27.3 7 27.3 7 50.0
Enterococcus faecalis 4 9.1
Enterococcus sp 7 8.3 2 27.3 4.5 18.2 6 18.2 5 20.0
Eubacterium lentum
Eubacterium sp
Fusobacterium fusiformes 3 8.3 1 9.1
Fusobacterium sp 2 8.3 4 9.1 2 18.2 2 18.2 3 10.0
Klebsiella pneumoniae
Klebsiella sp 3.5 16 2 45.5 3.5 18.2 7 36.4 9 10.0
Lactobacillus acidophillus
Lactobacillus sp 4 41.6 2 27.3 3 45.5 4 27.3 4.5 20.0
Leptotrichia sp 1 9.1
Peptococcus sp 3.5 16 2 9.1 3 9.1 3 27.3 4 30.0
Peptostreptococcus sp 5 8.1 3 10.0
Propionibacterium sp 3 8.1 2.5 18.2 9.1 2 36.4
Proteus sp 5 8.1 2 45.5 4 45.5 6 20.0
Pseudomonas sp
Rodothorula sp 4 8.1 1 9.1 4 18.2 4.5 20.0
Sarcinia lútea
Staphylococcus sp 2 8.1 1 9.1 18.2 2 45.5 3 50.0
Staphylococcus sp (coag-) 3 27.3
Streptococcus sp 4 2.5 2 27.3 4 9.1 5 10.0
(alpha hemolytic
viridans group)
Torulopsis sp 4 9.1
Veillonella sp 4 41.6 3 45.5 4 54.5 4 63.6 4 50.0
MC = mean concentration (UFC/log10); % = prevalence; sp = species; npg = nonpigmented; gel+ = gelatinase positive; gel- = gelatinase negative; npg =
nonpigmented; coag- = coagulase negative
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Klebisiella sp, Bacteroides sp (npg) start an ascending curve
of growth or “re-population” of the lower sites of the di-
gestive tract, being dormant in the stomach because of the
acidic environment.
Sample collection from small intestine segments is tech-
nically more difficult because of difficulties relating to ac-
cess and to the standardization of specific locations. Nev-
ertheless, it is of major interest because of the range of dis-
eases associated with alterations in its microbiota.44,45
Shiner46 developed a stainless steel capsule that only
opens at collection time to aspirate the contents of the je-
junum; this avoids contamination during its passage, but it
is very complex to use. Kalser et al6 developed a double
lumen polyvinyl catheter with a mercury weight on the
distal end for taking samples starting 75 cm from Treitz’s
ligament to near the distal ileum and cecal valve. However,
there was no mechanism to protect from contamination.
Their results were very similar to those of Shiner. 46
This method was tested in our midst by Machado et al,19
who collected samples of the jejunum liquid in patients suf-
fering from Chagasic achalasia. It was also used by
Quintanilha et al20,21 for qualitative evaluation of microbiota
alterations in the proximal jejunum of patients with
Chagasic megacolon, both before and after surgery.
A similar method has been used by different authors in
the study of bacterial translocation in critical patients.
Belov et al47 evaluated sepsis mediators (TNF and IL-1)
using jejunal aspiration in septic shock patients. Pardo et
al16 demonstrated a reduction in bacterial overgrowth and
translocation in cirrhotic patients using cisapride. Bernhardt
et al48 studied Candida sp colonization in digestive tracts
of critical patients under long-term antibiotic treatment.
In this study, the method of collecting mucus from the
upper digestive tract was used to evaluate healthy volun-
teers with the aim of establishing a normal pattern that
could serve as a control in studies of microbiotic changes
in disease states. Even though the sample group was small,
we obtained similar results to those described by Kalser6
and Shiner.46
It must be said that sample collection from the jejunum
and proximal ileum is an uncomfortable procedure for the
patient. Therefore, recruiting healthy volunteers is not easy;
this makes it difficult for researchers to recruit control
groups for their studies.
The study of lower digestive tract microbiota is a ma-
jor challenge because of the high concentration and vari-
ety of microorganisms pertaining to the indigenous and
transitory microbiota.49 In early trials in which researchers
attempted to study the microbiology of dregs,4,5 they were
unable to differentiate indigenous from transitory
microbiota or determine the different levels of bacteria in
the different segments of the lower digestive tract. Studies
that have employed sample collection during laparotomy50
have not respected the physiological conditions of the pa-
tient, because the quantitative study was prejudiced due to
dilution of mucus during collection.
The need for more precise and reliable methods moti-
vated us to develop a special catheter to collect adequate
volume of undiluted mucus from specific regions of the
lower digestive tract during colonoscopy using an aseptic
technique. This is an efficient method as shown by the large
variety of aerobic, anaerobic, microaerophile, and faculta-
tive microorganisms, and yeasts obtained. The results show
a stable increase in anaerobic microorganisms (Veillonella
sp, Peptococcus sp, and Fusobacterium sp) with the capac-
ity to digest amino acids but with little ability to ferment
carbohydrates. These and other similar microorganisms
comprise a distinct metabolism group in the large intes-
tine.4
There was also the constant presence of other bacteria
with average concentrations of 105 such as Clostridium sp
(gel-) Corynebacterium sp, E. coli, Enterobacter sp,
Klebisiella sp, Lactobacillus sp, Propionibacterium sp, Pro-
teus sp, and Veillonella sp; there were others at lower con-
centrations.
Bacterial types were characterized colonizing restricted
areas of the lower digestive tract with average concentra-
tions of 105 (Table 5); the following could be interpreted
as “biological markers” of health: Fusobacterium sp in the
rectum; Peptococcus sp in the sigmoid; and Enterococcos
sp in the transverse colon. Bacteroides sp tend to reside in
the more proximal regions, gradually decreasing in preva-
lence in the sigmoid and rectum.
CONCLUSION
The presented sampling collection methods are safe and
efficient for obtaining suitable samples of mucus for quali-
tative and quantitative microbiologic studies, revealing an
environment of low oxidation-reduction (redox) potential.
These results open the possibility for many other stud-
ies in this area, using low-risk and highly reliable method-
ology, to define the role of microbiota in the other
gastrointestinal diseases as well as for standardization of
future prophylactic treatment50,51 in gastroenterology.
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RESUMO
Zilberstein B, Quintanilha AG, Santos MAA, Pajecki D,
Moura EG, Alves PRA, Maluf Filho F, Souza JAU de,
Gama-Rodrigue J. Microbiota no trato digestivo em volun-
tários saudáveis. Clinics. 2007:62(1):47-54.
OBJETIVO: Padronizar os métodos de coleta do muco do
trato digestivo e determinar a microbiota, em voluntários
saudáveis no Brasil, coletando amostras da boca, esôfago,
estômago, duodeno, jejunos e íleo, cólons e reto.
MÉTODOS: A microbiota de voluntários saudáveis foi ava-
liada através de diferentes métodos de coleta: cavidade oral
(n=10 voluntários), do esôfago (n=10), do trato digestivo alto
(n=20) e do trato digestivo baixo (n=24). Métodos de cole-
ta foram adotados em cada sítio restrito, usando derramar
saliva, técnica de esfregar a mucosa e saliva estimulada da
cavidade oral, irrigação-aspiração, cateteres específicos de-
signados para o esôfago, sonda especial para o trato digesti-
vo alto e cateteres especiais para o trato digestivo baixo.
RESULTADOS: Identificados: (i) na cavidade oral,
microbiota mista, predominando cocos aeróbios e
anaeróbios Gram positivos; (ii) no esôfago, flora transitó-
ria; (iii) no estômago e duodeno, Veillonella sp,
Lactobacillus sp and Clostridium sp; (iv) no jejuno e íleo
proximal, Bacteróides sp, Proteus sp and Staphilococcus
sp, além da Veillonella sp ; (v) no colon, foi revelada a pre-
sença “não patogênica” da bactéria anaeróbica Veillonella
sp numa concentração média de 105 unidades formadoras
de colônia, indicando um meio de baixo potencial de oxi-
do-redução e a possibilidade de se conceituar esta bacté-
ria como um marcador biológico do trato digestivo total
em sadios.
CONCLUSÃO: Estes métodos de coleta foram conside-
rados eficientes para obtenção adequada de amostra em
cada segmento do trato digestivo total para caracterizar a
microbiota normal.  Estes procedimentos são seguros e fa-
cilmente reprodutível para estudo microbiológico.
UNITERMOS: Bactérias Anaeróbias. Bactérias Aeróbias.
Fungos. Contagem de Colônia Microbiana. Trato
Gastrointestinal.
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Table 4 - Mean Concentration and Prevalence (%) of Microorganisms in each Site of the LDT
ÍLEUM  CECUM COLON RECTUM
Ascending Transverse Descending Sigmoid
Microorganisms MC % MC % MC % MC % MC % MC % MC %
Bacillus sp 1 9.5 2 4.2 5 4.2 3 4.2 1 4.3 3 5.0
Bacteroide sp (pig.) 5 4.8 5 4.3 1 5.0
Bacteroides sp (npg) 3 47.6 5 29.2 4 37.5 5 12.5 5 12.5 5 47.8 5 65.0
Bacteroides sp 2 4.8 2 4.2 3 5.0
Bifidobacterium sp 2 9.5 3 4.2 4 4.2 4 8.3 4 8.7 3 5.0
Candida sp 3.5 9.5 2 20.8 3 20.8 2 29.2 4 16.7 3 34.8 3 35.0
Clostridium rammosum 1 4.8 3 4.2
Clostridium sp (gel -) 4 66.7 4 45.8 5 50.0 4.5 58.3 5 54.2 5 69.6 7 60.0
Clostridium sp (gel+) 2 4.2 4 4.2 3 5.0
Clostridium sp 1 4.8 4 45.8 7 4.2 5 5.0
Corynebacterium sp 3 57.1 3 54.2 3.5 50.0 4 41.7 4 45.8 5 60.9 5 65.0
E.coli 5 47.6 5 37.5 5 45.8 4.5 50.0 5 37.5 5 69.6 7 80.0
Enterobacter cloacae 4 4.2 1 4.2
Enterobacter sp 4 28.6 4 20.8 7 37.5 4 29.2 5 45.8 5 52.2 7 35.0
Enterococcus faecalis 4.5 9.5 3 4.2 4 4.2 3 4.2 1 4.2 4 8.7
Enterococcus faecium 5 4.2
Enterococcus sp 4 38.1 2.5 33.3 3.5 33.3 3 58.3 5 58.3 5 34.8 5 60.0
Eubacterium lentum 4 4.8
Eubacterium sp 3.5 9.5
Fusobacterium fusiformes 3 4.8
Fusobacterium sp 3.5 19.0 2.5 25.0 3 20.8 4 16.7 4 8.3 3 21.7 4 55.0
Klebsiella pneumoniae 5 4.2
Klebsiella sp 5 76.2 4 54.2 6 62.5 5 54.2 5 41.7 7 69.6 7 65.0
Lactobacillus acidophillus 4 4.8 3 4.2
Lactobacillus sp 4 33.3 2 29.2 2.5 33.3 3 37.5 3 25.0 2 43.5 4 70.0
Leptotrichia sp 1 4.2 1 4.3
Peptococcus anaerobius 2 4.8 4 4.2 2 4.2 1 4.3
Peptococcus assachalyticus 2 4.8
Peptococcus sp 2 28.6 2.5 33.3 3 25.0 3 33.3 3 25.0 3 56.5 3 35.0
Peptostreptococcus sp 3 9.5 2 8.3 1 4.2 5 13.0
Propionibacterium sp 3 52.4 3 20.8 4 33.3 3 50.0 3 29.2 5 26.1 5 30.0
Proteus sp 3.5 19.0 4 12.5 5 33.3 5 37.5 5 25.0 7 34.8 7 30.0
Pseudomonas sp 3 9.5 1 4.2
Rodothorula sp 4 14.3 2 20.8 1 4.2 1 12.5 3 16.7 1 4.3 3.5 20.0
Selenomonas sp 2 5.0
Staphylococcus sp 5 4.8 2 4.2
Staphylococcus sp coag - 2 33.3 2 20.8 1.5 8.3 2 20.8 2 8.3 3 21.7 3 45.0
Staphylococcus sp (coag+ 3 5.0
Streptococcus/ gama hem 2 8.3
Streptococcussp/alfa 4 14.3 4 16.7 2 8.3 3.5 8.3 2 13.0 3 5.0
hemolítico grupo Viridans
Veillonella sp (Gel - ) 3 8.3
Veillonella sp 4 90.5 2.5 83.3 4 70.8 4 62.5 5 75.0 5 95.7 5 90.0
MC = Mean concentration (UFC / Log10), % = prevalence
Table 5 - Association between microorganisms/sites of the lower digestive tract
Microbiota Lower Digestive Tract site
Klebisiella sp, Clostridium sp (gel-), Veillonella sp All sites
Enterobacter sp Sigmoid*
Cândida sp Sigmoid and Rectum*
Enterococcus sp e Lactobacillus sp Rectum*
sp = species, *p < 0,05 or < 5%
This article has received corrections in agreement with the ERRATUM published in Volume 62 Number 2.
